Sorafenib treatment also inhibited tumor metastasis by inhibiting the EMT pathway [24,25]; however, whether downregulation of the HMGCS2 gene altered sorafenib-induced EMT inhibition remains unknown. The gene discussed is HMGCS2; the disease is neoplasm.